Overview The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration Status: Completed Trial end date: 2008-12-01 Target enrollment: Participant gender: Summary The goal of this study is to develop and evaluate an innovative model of care to better serve patients who are both HIV-infected and opioid-dependent. Details Lead Sponsor: Ruth M. Rothstein CORE CenterCollaborators: Health Resources and Services Administration (HRSA)The New York Academy of MedicineTreatments: BuprenorphineBuprenorphine, Naloxone Drug CombinationMethadoneNaloxone